New research from Virginia Tech suggests that memory decline in older adults may be reversible through gene therapy. Scientists have identified a key molecular mechanism—K63 polyubiquitination—that plays a critical role in age-related memory loss. By using CRISPR technology to target this pathway, they successfully improved memory performance in elderly mice.
The study offers hope for developing treatments for dementia and other cognitive disorders. The findings indicate that memory loss is not solely a result of aging but involves specific molecular changes in the brain. CRISPR-based interventions could potentially reset these changes, restoring cognitive function.
While further research is needed before human trials, this breakthrough highlights the potential of gene editing to address neurological conditions. For more details, visit pomodo.id.